• ABDUL HASEEB Department of Paediatrics, Esic Medical College and Hospital, Kalaburagi, Karnataka, India
  • SHARANABASAPPA Department of Paediatrics, Esic Medical College and Hospital, Kalaburagi, Karnataka, India
  • HAREESH Department of Paediatrics, Esic Medical College and Hospital, Kalaburagi, Karnataka, India



Dengue fever, Pediatric patients, Clinical features, Laboratory findings, Diagnostic correlation


Objective: Dengue fever poses a significant challenge to global health, particularly affecting children in endemic regions. The diverse clinical presentations, ranging from mild to severe forms such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), complicate its diagnosis and management in pediatric populations. Understanding the clinical nuances is crucial, given the substantial global burden of dengue.

Methods: This prospective cross-sectional study conducted at the Department of Pediatrics, Yashoda Super Specialty Hospital, aimed to investigate the clinical, laboratory, and radiological features of dengue fever in pediatric patients aged 6 mo to 16 y. Data collection involved demographic details, clinical presentations, laboratory findings, and treatment administered. Statistical analysis was performed using SPSS version 19.0.

Results: Among the 100 enrolled pediatric patients, high fever (100%), headache (75%), myalgia (70%), rash (65%), and hemorrhagic manifestations (40%) were prevalent clinical features. Laboratory findings revealed thrombocytopenia in 60% of cases and elevated liver enzymes in 30%. Correlation analyses identified associations between specific symptoms and diagnostic findings, aiding in the recognition of severe cases such as DSS.

Conclusion: The study highlights the diverse clinical spectrum of pediatric dengue, emphasizing the importance of vigilant clinical assessment and laboratory testing for timely diagnosis and management. These insights are essential for optimizing patient care and outcomes, particularly in endemic regions.


Download data is not yet available.


World Health Organization. Dengue and severe dengue; 2021. Available from:

Guzman MG, Harris E. Dengue. Lancet. 2015;385(9966):453-65. doi: 10.1016/S0140-6736(14)60572-9, PMID 25230594.

Halstead SB. Dengue. Lancet. 2007;370(9599):1644-52. doi: 10.1016/S0140-6736(07)61687-0, PMID 17993365.

Capeding MR, Tran NH, Hadinegoro SR, Ismail HI, Chotpitayasunondh T, Chua MN. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014;384(9951):1358-65. doi: 10.1016/S0140-6736(14)61060-6, PMID 25018116.

Kalayanarooj S, Nimmannitya S. Is dengue severity related to nutritional status? Southeast Asian J Trop Med Public Health. 2005;36(2):378-84. PMID 15916044.

Shepard DS, Undurraga EA, Betancourt Cravioto M, Guzmán MG, Halstead SB, Harris E. Approaches to refining estimates of global burden and economics of dengue. PLOS Negl Trop Dis. 2014;8(11):e3306. doi: 10.1371/journal.pntd.0003306, PMID 25412506.

Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL. The global distribution and burden of dengue. Nature. 2013;496(7446):504-7. doi: 10.1038/nature12060, PMID 23563266.

World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention, and control; 2009. Available from:

Ranjit S, Kissoon N, Jayakumar I. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggested protocol. Pediatr Crit Care Med. 2005;6(4):412-9. doi: 10.1097/01.PCC.0000163676.75693.BF, PMID 15982427.

Takei T, Fukushima H, Hatakeyama J, Fujisawa M, Ito T. Acute amiodarone poisoning occurring twice in the same subject. Clin Toxicol. 2011;49(10):944-5. doi: 10.3109/15563650.2011.629201.

Masters E, Crist C. Erythema migrans associated with intravenous cephalosporin therapy. The Pediatric Infectious Disease Journal. 2002;21(4). doi: 10.1097/00006454-200204000-00025.

Blacksell SD. Commercial dengue rapid diagnostic tests for point-of-care application: recent evaluations and future needs? J Biomed Biotechnol. 2012;2012:151967. doi: 10.1155/2012/151967, PMID 22654479.

Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12)Suppl:S7-S16. doi: 10.1038/nrmicro2460, PMID 21079655.



How to Cite

HASEEB, A., SHARANABASAPPA, and HAREESH. “CLINICAL PRESENTATION AND MANAGEMENT OF DENGUE IN PEDIATRIC PATIENTS”. International Journal of Current Pharmaceutical Research, vol. 16, no. 3, May 2024, pp. 24-26, doi:10.22159/ijcpr.2024v16i3.4055.



Original Article(s)